Search

Displaying results 7051 - 7060 of 10000 in total
  1. Drug

    Ancriviroc

    go.drugbank.com/drugs/DB19773
    Experimental

    The usage of the INN stem '-viroc' in the name indicates that Ancriviroc is a CCR5 (Chemokine CC motif receptor 5) receptor antagonist. Ancriviroc has a monoisotopic molecular weight of 556.2 Da.

  2. Drug

    Diclofenac etalhyaluronate

    go.drugbank.com/drugs/DB20937
    Experimental

    Diclofenac etalhyaluronate has a monoisotopic molecular weight of 1475.39 Da. … The usage of the INN stem '-ac' in the name indicates that Diclofenac etalhyaluronate is a anti-inflammatory agent, ibufenac derivative.

  3. Drug

    Xemilofiban

    go.drugbank.com/drugs/DB21058
    Experimental

    Xemilofiban has a monoisotopic molecular weight of 358.16 Da. … The usage of the INN stem '-fiban' in the name indicates that Xemilofiban is a fibrinogen receptor antagonist (glycoprotein IIb/IIIa receptor antagonist).

  4. Drug

    Imdatifan

    go.drugbank.com/drugs/DB21643
    Experimental

    The usage of the INN stem '-tifan' in the name indicates that Imdatifan is a hypoxia inducible factor (HIF)-2alpha (HIF-2a) inhibitor. Imdatifan has a monoisotopic molecular weight of 385.05 Da.

  5. Drug

    Renzapride

    go.drugbank.com/drugs/DB04917
    Investigational

    It has been suggested that renzapride is effective in the treatment of irritable bowel syndrome with alternating stool pattern. It is being developed by Alizyme of the UK. … Renzapride is currently in Phase III clinical development in the United States for the treatment of constipation-predominant irritable bowel syndrome (IBS-C).

  6. Drug

    Rolitetracycline

    go.drugbank.com/drugs/DB01301
    ApprovedWithdrawn

    A pyrrolidinylmethyl tetracycline.

    Synonyms: N-(Pyrrolidinomethyl)tetracycline, N-(1-Pyrrolidinylmethyl)-tetracycline
  7. Drug

    Adomeglivant

    go.drugbank.com/drugs/DB11704
    Investigational

    Adomeglivant has been investigated for the basic science of Type 2 Diabetes.

  8. Drug

    Mapracorat

    go.drugbank.com/drugs/DB12041
    Investigational

    Mapracorat has been investigated for the treatment of Eczema and Atopic Dermatitis.

  9. Drug

    Oxitropium

    go.drugbank.com/drugs/DB12086
    Investigational

    Oxitropium has been investigated for the treatment of Pulmonary Disease, Chronic Obstructive.

  10. Drug

    Losmapimod

    go.drugbank.com/drugs/DB12270
    Investigational

    Losmapimod has been investigated for the prevention of Chronic Obstructive Pulmonary Disease.